Search research articles

关于 JoVE

概览领导团队博客 JoVE 帮助中心

作者

出版流程编辑委员会范围与政策同行评审常见问题投稿

图书馆员

用户评价订阅访问资源图书馆顾问委员会常见问题

研究

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments 存档

教育

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual 教师资源中心教师网站

使用条款与条件

相关概念视频

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序

Same author

Pathogenic properties of myasthenia gravis AChR autoantibodies associate with clinical response to efgartigimod.

Journal of neurology, neurosurgery, and psychiatry·2026

Same author

Generation of Monoclonal Autoantibodies From Myelin Oligodendrocyte Glycoprotein-Specific Human B Cells Using an Optofluidic-Based Platform.

Neurology(R) neuroimmunology & neuroinflammation·2026

Same author

Engineered Bi-Specific AChR CAAR T Cells for Selective Elimination of Myasthenia Gravis B Cells.

Research square·2026

Same author

IgG4 on the dance floor: Partners swapped by Fab-arm exchange.

Science immunology·2026

Same author

IgA autoantibodies demonstrate a novel mechanism of MuSK myasthenia gravis pathology.

Brain : a journal of neurology·2025

Same author

Screening for Congenital Myasthenic Syndromes in Adults With Seronegative Myasthenia Gravis Using Next-Generation Sequencing.

Neurology·2025

Search research articles

相关实验视频

Updated: Jul 15, 2026

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

隐藏和去PhiP-Seq:找到一个难以捉摸的预测性MS生物标志物

Annabel Wallace¹, Kevin C O'Connor¹

¹Departments of Neurology and Immunobiology, Yale University School of Medicine, New Haven, CT, USA.

Science immunology

|June 7, 2024

概括

研究人员确定了一种独特的免疫系统模式或自身抗体特征,这种特征出现在多发性硬化症 (MS) 症状出现之前. 这一发现为早期发现多发性硬化症提供了潜力.

科学领域:

免疫学免疫学免疫学
神经学神经学
蛋白质组学是指蛋白质组学.

背景情况:

多发性硬化症 (MS) 是一种慢性自身免疫性疾病,影响中枢神经系统.
由于MS的临床表现变化和症状往往晚发,因此早期发现MS具有挑战性.

研究的目的:

调查通过全蛋白质组分析检测到的自身抗体特征是否可以预测多发性硬化症的临床发病.

主要方法:

利用全蛋白质体自身抗体分析来分析免疫反应.
在MS临床诊断之前和之后,对个体的自身抗体概况进行比较.

主要成果:

鉴定出一种独特的免疫学特征,其特征是特定的自身抗体.
发现这种特征在多发性硬化症临床表现之前出现.

结论:

全蛋白质组自身抗体分析可以揭示与多发性硬化症相关的免疫特征.
这种特征有可能作为预测MS发病的早期生物标志物.

更多相关视频

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

Quantification of Protein Interaction Network Dynamics using Multiplexed Co-Immunoprecipitation

Quantification of Protein Interaction Network Dynamics using Multiplexed Co-Immunoprecipitation

Published on: August 21, 2019

相关实验视频

Last Updated: Jul 15, 2026

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

Quantification of Protein Interaction Network Dynamics using Multiplexed Co-Immunoprecipitation

Quantification of Protein Interaction Network Dynamics using Multiplexed Co-Immunoprecipitation

Published on: August 21, 2019